Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b

Journal of Cancer Research and Clinical Oncology

Volumn 142, Issue 6, 2016, Pages 1261-1271

  Maushagen, Regina ^a   Reers, Stefan ^b   Pfannerstill, Ann Christin ^c   Hahlbrock, Angelina ^d   Stauber, Roland ^d   Rahmanzadeh, Ramtin ^e   Rades, Dirk ^a   Pries, Ralph ^a   Wollenberg, Barbara ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Apoptosis; Caspase 9b; Caspases; Head and neck cancer; Paclitaxel

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 10; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE 9B; PACLITAXEL; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; APAF1 PROTEIN, HUMAN; STAUROSPORINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MITOCHONDRIAL MEMBRANE POTENTIAL; OUTER MEMBRANE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA CELL LINE; ALTERNATIVE RNA SPLICING; CELL CYCLE; CELL DEATH; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEAD AND NECK TUMOR; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CARCINOMA, SQUAMOUS CELL; CASPASE 9; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; DNA METHYLATION; ENZYME ACTIVATION; HEAD AND NECK NEOPLASMS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PACLITAXEL; PROMOTER REGIONS, GENETIC; STAUROSPORINE;

EID: 84962148542     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-016-2150-3     Document Type: Article

References (39)

1. Adrain C, Slee EA, Harte MT, Martin SJ (1999) Regulation of apoptotic protease activating factor-1 oligomerization and apoptosis by the WD-40 repeat region. J Biol Chem 274:20855–20860
2. Ahmad ST, Arjumand W, Seth A, Saini AK, Sultana S (2012) Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population. Tumour Biol 33:395–402. doi:10.1007/s13277-011-0235-9
3. Bala S et al (2000) Genetic analysis of the APAF1 gene in male germ cell tumors. Genes Chromosom Cancer 28:258–268
4. Baylin S, Bestor TH (2002) Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1:299–305
5. Chang YF, Li LL, Wu CW, Liu TY, Lui WY, P’Eng FK, Chi CW (1996) Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer 77:14–18
6. Furukawa Y et al (2002) Apaf-1 is a mediator of E2F-1-induced apoptosis. J Biol Chem 277:39760–39768
7. Furukawa Y, Sutheesophon K, Wada T, Nishimura M, Saito Y, Ishii H, Furukawa Y (2005) Methylation silencing of the Apaf-1 gene in acute leukemia. Mol Cancer Res 3:325–334
8. Hakem R et al (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94:339–352
9. Hinz S, Kempkensteffen C, Weikert S, Schostak M, Schrader M, Miller K, Christoph F (2007) EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder. Tumour Biol 28:151–157. doi:10.1159/000103380
10. Hu Y, Benedict MA, Ding L, Nunez G (1999) Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J 18:3586–3595. doi:10.1093/emboj/18.13.3586
11. Ibrado AM, Kim CN, Bhalla K (1998) Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells. Leukemia 12:1930–1936
12. Kuida K et al (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94:325–337
13. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489
14. Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC (1993) Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res 53:2066–2070
15. Lin HL, Chang YF, Liu TY, Wu CW, Chi CW (1998) Submicromolar paclitaxel induces apoptosis in human gastric cancer cells at early G1 phase. Anticancer Res 18:3443–3449
16. Liu JR, Opipari AW, Tan L, Jiang Y, Zhang Y, Tang H, Nunez G (2002) Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res 62:924–931
17. Malladi S, Challa-Malladi M, Fearnhead HO, Bratton SB (2009) The Apaf-1*procaspase-9 apoptosome complex functions as a proteolytic-based molecular timer. EMBO J 28:1916–1925
18. Manns J et al (2011) Triggering of a novel intrinsic apoptosis pathway by the kinase inhibitor staurosporine: activation of caspase-9 in the absence of Apaf-1. FASEB J 25:3250–3261. doi:10.1096/fj.10-177527
19. Mielgo A, Torres VA, Clair K, Barbero S, Stupack DG (2009) Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubules. Oncogene 28:3551–3562
20. Norbury CJ, Zhivotovsky B (2004) DNA damage-induced apoptosis. Oncogene 23:2797–2808
21. Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR (2004) Taxol induces caspase-10-dependent apoptosis. J Biol Chem 279:51057–51067. doi:10.1074/jbc.M406543200
22. Paska AV, Hudler P (2015) Aberrant methylation patterns in cancer: a clinical view. Biochem Med 25:161–176. doi:10.11613/BM.2015.017
23. Perkins CL, Fang G, Kim CN, Bhalla KN (2000) The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res 60:1645–1653
24. Riccardi C, Nicoletti I (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1(3):1458–1461. doi:10.1038/nprot.2006.238
25. Rowinsky EK, Donehower RC (1995) Paclitaxel (taxol). N Engl J Med 332:1004–1014
26. Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665–667
27. Seol DW, Billiar TR (1999) A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J Biol Chem 274:2072–2076
28. Shultz JC, Goehe RW, Wijesinghe DS, Murudkar C, Hawkins AJ, Shay JW, Minna JD, Chalfant CE (2010) Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a. Cancer Res 70(2):9185–9196. doi:10.1158/0008-5472.CAN-10-1545
29. Soengas MS et al (2001) Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409:207–211. doi:10.1038/35051606
30. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES (1998) Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1:949–957
31. Srinivasula SM, Ahmad M, Guo Y, Zhan Y, Lazebnik Y, Fernandes-Alnemri T, Alnemri ES (1999) Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. Cancer Res 59:999–1002
32. Stepczynska A, Lauber K, Engels IH, Janssen O, Kabelitz D, Wesselborg S, Schulze-Osthoff K (2001) Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene 20:1193–1202. doi:10.1038/sj.onc.1204221
33. Sugimura M, Sagae S, Ishioka S, Nishioka Y, Tsukada K, Kudo R (2004) Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone. Oncology 66:53–61. doi:10.1159/000076335
34. Vegran F, Boidot R, Solary E, Lizard-Nacol S (2011) A short caspase-3 isoform inhibits chemotherapy-induced apoptosis by blocking apoptosome assembly. PLoS ONE 6:e29058. doi:10.1371/journal.pone.0029058
35. Vermorken JB (2005) Medical treatment in head and neck cancer. Ann Oncol 16(Suppl. 2):ii258–ii264. doi:10.1093/annonc/mdi735
36. Wang TH, Wang HS, Soong YK (2000) Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88:2619–2628
37. Watanabe T et al (2003) Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma. Brain Pathol 13:431–439
38. Yamamoto H, Gil J, Schwartz S Jr, Perucho M (2000) Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype. Cell Death Differ 7:238–239
39. Yu J et al (2002) Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2:29